DLBCL

Clinical trials for DLBCL explained in plain language.

Never miss a new study

Get alerted when new DLBCL trials appear

Sign up with your email to follow new studies for DLBCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 3 Not yet finished but already full! 9 Completed 1

Engineered immune cells take aim at Hard-to-Treat blood cancers

Disease control Completed

This study tested whether a new type of immune cell therapy, called CD22 CAR T cells, could be made from the blood of adults with certain blood cancers (leukemia and lymphoma) that had come back or not responded to treatment. The main goals were to see if the cells could be succe…

Matched conditions: DLBCL

Phase: PHASE1 • Sponsor: Matthew Frank • Aim: Disease control

Last updated May 17, 2026 05:21 UTC

DLBCL

Get alerted when new DLBCL trials appear

Engineered immune cells take aim at Hard-to-Treat blood cancers